Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Syneos Health Inc (SYNH)  
$42.98 0.00 (0.00%) as of 4:30 Wed 9/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 104,310,000
Market Cap: 4.48(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $41.73 - $42.98
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  779
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Syneos Health is a holding company. Through its subsidiaries, Co. is a biopharmaceutical solutions organization. Co. has two segments: Clinical Solutions, which provides a variety of services spanning Phase I to Phase IV of clinical development, including global studies, as well as individual service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process; and Commercial Solutions, which provides commercialization services, including deployment solutions, communication solutions (public relations, advertising, and medical communications), and consulting services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 23,703
Total Sell Value $0 $0 $0 $1,745,443
Total People Sold 0 0 0 5
Total Sell Transactions 0 0 0 10
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 638
  Page 23 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-12-31 4 AS $46.67 $456,207 D/D (9,468) 7,291     -
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-12-31 4 OE $10.06 $97,662 D/D 9,468 12,025     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-12-31 4 AS $46.52 $1,710,210 D/D (35,503) 8,132     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-12-31 4 OE $10.06 $357,160 D/D 35,503 43,635     -
   Ogle James T. Director   –       •      –    2015-12-29 4 AS $50.06 $486,452 D/D (9,717) 183,386     -
   Ogle James T. Director   –       •      –    2015-12-29 4 OE $8.45 $82,109 D/D 9,717 193,103     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-12-08 4 AS $45.43 $2,149,293 D/D (47,310) 8,132     -
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-12-08 4 AS $35.36 $583,737 D/D (14,703) 7,291     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-12-07 4 AS $44.70 $1,507,687 D/D (33,725) 55,442     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-12-07 4 OE $10.06 $815,212 D/D 81,035 89,167     -
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-12-07 4 AS $44.70 $468,602 D/D (10,482) 21,994     -
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-12-07 4 OE $10.06 $260,497 D/D 25,185 32,476     -
   Macdonald Alistair Chief Operating Officer   •       –      –    2015-12-07 4 AS $44.49 $1,917,397 D/D (42,959) 55,681     -
   Macdonald Alistair Chief Operating Officer   •       –      –    2015-12-07 4 OE $8.45 $363,004 D/D 42,959 98,640     -
   Inc Research Mezzanine Co-Invest, Llc 10% Owner   –       –       •   2015-12-07 4 S $45.00 $206,907,165 I/I (4,597,937) 10,761,139     -
   1829356 Ontario Ltd 10% Owner   –       –       •   2015-12-07 4 S $45.00 $198,092,835 I/I (4,402,063) 10,302,711     -
   Gibertini Michael President Clinical Development   •       –      –    2015-12-01 4 AS $45.71 $418,662 D/D (9,000) 36,282     -
   Gibertini Michael President Clinical Development   •       –      –    2015-12-01 4 OE $8.45 $76,050 D/D 9,000 45,282     -
   Gibertini Michael President Clinical Development   •       –      –    2015-11-02 4 AS $41.70 $375,300 D/D (9,000) 36,282     -
   Gibertini Michael President Clinical Development   •       –      –    2015-11-02 4 OE $8.45 $76,050 D/D 9,000 45,282     -
   Macdonald Alistair Chief Operating Officer   •       –      –    2015-09-28 4 AS $38.84 $1,777,629 D/D (44,522) 55,681     -
   Macdonald Alistair Chief Operating Officer   •       –      –    2015-09-28 4 OE $8.45 $376,211 D/D 44,522 100,203     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-09-14 4 AS $44.74 $1,460,999 D/D (32,426) 8,132     -
   Rush Gregory S Executive VP and CFO   •       –      –    2015-09-14 4 OE $10.06 $326,206 D/D 32,426 40,558     -
   Gaenzle Christopher L CAO, GC & Sec   •       –      –    2015-08-31 4 AS $41.13 $717,106 D/D (17,421) 7,291     -
  638 Records found
  Previous  20  21  22  23  24  25  26   
  Page 23 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us